Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by mmarquison Jul 22, 2011 8:03pm

365 Views

Post# 18863932

RE: RE: Bizarre 20 % price climb for ONCY (America

I think there is a problem with the market feed. Doesn't see likely that it will jump from a last sale of 4.55 at the close to an after close of 5.49 on only 400 shares, which is higher than the ask at the time. Most platforms would'nt even allow the request to be entered. we'll see come Monday.
M

Bullboard Posts

How one company is disrupting PoC testing